Barinthus Biotherapeutics plc (BRNS) — Capital Reinvestment Ratio

Latest as of December 2024: 0.02x

Barinthus Biotherapeutics plc (BRNS) has a Capital Reinvestment Ratio of 0.02x as of December 2024, meaning it reinvests 0% of its operating cash flow ($13.09 Million) in capital expenditures ($278.00K). See BRNS equity to assets ratio to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.02x

Capex / Operating Cash Flow

Operating Cash Flow

$13.09 Million

USD

Capital Expenditures

$278.00K

USD

Data as of

Dec 2024

Most recent filing

Annual Capital Reinvestment Ratio for Barinthus Biotherapeutics plc (None–None)

Year-by-year Capital Reinvestment Ratio for Barinthus Biotherapeutics plc from None to None. For live market cap and broader valuation context, see BRNS company net worth.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow